共 50 条
- [31] Comparison of Efficacy and Safety of Leptin Replacement Therapy in Moderately and Severely Hypoleptinemic Patients with Familial Partial Lipodystrophy of the Dunnigan Variety JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (03): : 785 - 792
- [34] A case of Dunnigan-type familial partial lipodystrophy (FPLD) due to lamin A/C (LMNA) mutations complicated by end-stage renal disease Endocrine, 2009, 35 : 18 - 21
- [35] Mesangiocapillary glomerulonephritis type 2 associated with familial partial lipodystrophy (Dunnigan-Kobberling syndrome) NEPHRON CLINICAL PRACTICE, 2004, 96 (02): : C35 - C38
- [36] Endoplasmic reticulum stress activation in adipose tissue induces metabolic syndrome in individuals with familial partial lipodystrophy of the Dunnigan type Diabetology & Metabolic Syndrome, 10
- [37] Endoplasmic reticulum stress activation in adipose tissue induces metabolic syndrome in individuals with familial partial lipodystrophy of the Dunnigan type DIABETOLOGY & METABOLIC SYNDROME, 2018, 10
- [39] A LMNA splicing mutation in two sisters with severe dunnigan-type familial partial lipodystrophy type 2 JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (07): : 2689 - 2695